My Account Log Out
 
 
Daniel Bellinger

Daniel Bellinger Receiving TD
Player Prop Week 14

New York Giants vs Philadelphia Eagles

 
 
 
Daniel Bellinger Receiving TD Prop is currently Over/Under 0.5 (+390/-818).

The money has been on the Over as it opened 0.5 @ +439 before it was bet up to 0.5 @ +390.
FACTORS THAT FAVOR THE OVER:
  • The Giants are a 6.5-point underdog in this week's contest, likely creating a passing game script.
  • THE BLITZ projects the Giants to call the 2nd-most offensive plays among all teams this week with 68.5 plays, accounting for their underlying tendencies and game dynamics.
  • The New York Giants have called the 8th-most plays in football this year, totaling a whopping 60.0 plays per game.
  • The Philadelphia Eagles safeties rank as the 3rd-worst unit in the league this year in covering receivers.
  • The New York Giants have incorporated play action on 28.4% of their passing plays since the start of last season (10th-most in the NFL), tricking the defense into thinking it's a run and leading to much higher passing efficiency.

  • FACTORS THAT FAVOR THE UNDER:
  • Opposing QBs have averaged 34.4 pass attempts per game against the Philadelphia Eagles defense this year: 6th-least in the NFL.
  • The New York Giants O-line ranks as the 9th-worst in football this year in protecting the QB, which has a negative effect on all passing attack stats across the board.
  • The Philadelphia Eagles pass defense has yielded the 3rd-lowest Completion% in football (63.4%) versus TEs this year (63.4%).
  • The New York Giants O-line has allowed their QB a mere 2.41 seconds before getting pressured (8th-worst in football since the start of last season), which has a harmful impact on all passing attack metrics across the board.
  • The Philadelphia Eagles defense has gotten pressure on opposing QBs a measly 2.40 seconds after the snap (on average), grading out as the 7th-quickest in the league since the start of last season.

  •  
     
     
     
     
    © 2022 EV Analytics   |   Data by WriteNow™